切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (05) : 440 -443. doi: 10.3877/cma.j.issn.2095-3224.2016.05.014

所属专题: 经典病例 文献

经验交流

结直肠神经内分泌肿瘤25例临床分析
廖波1, 魏少忠1,(), 黄小辉1   
  1. 1. 430071 武汉大学中南医院肿瘤科;430079 武汉,湖北省肿瘤医院胃肠外科
  • 收稿日期:2016-05-22 出版日期:2016-10-25
  • 通信作者: 魏少忠

Clinical analysis of 25 cases with colorectal neuroendocrine neoplasm

Bo Liao1, Shaozhong Wei1,(), Xiaohui Huang1   

  1. 1. Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Gastrointestinal Surgery, Hubei Cancer Hospital, Wuhan 430079, China
  • Received:2016-05-22 Published:2016-10-25
  • Corresponding author: Shaozhong Wei
  • About author:
    Corresponding author: Wei Shaozhong, Email:
引用本文:

廖波, 魏少忠, 黄小辉. 结直肠神经内分泌肿瘤25例临床分析[J]. 中华结直肠疾病电子杂志, 2016, 05(05): 440-443.

Bo Liao, Shaozhong Wei, Xiaohui Huang. Clinical analysis of 25 cases with colorectal neuroendocrine neoplasm[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(05): 440-443.

目的

探讨结直肠神经内分泌肿瘤的临床特征、诊治方法及预后。

方法

回顾分析湖北省肿瘤医院自2006年1月至2015年1月收治的25例结直肠神经内分泌肿瘤患者的临床资料。

结果

肿瘤部位:阑尾3例,升结肠3例,乙状结肠2例,直肠17例。分级情况:NET(G1)11例,NET(G2)3例,NEC(G3)8例,MANEC 3例。免疫组织化学:Syn、CgA、NSE阳性表达率为96%,68%和92%。预后:结直肠神经内分泌肿瘤出现转移部位最多见为肝脏。9例Ⅰ期患者生存时间均长于5年。6例Ⅱ期患者,3年内死亡1例,5年内死亡3例,余1例仍在随访中。8例Ⅲ期患者,1年生存率75%,3年生存率50%,5年生存率25%。2例Ⅳ期患者,1例存活28月,另1例存活37月。

结论

结直肠神经内分泌肿瘤缺乏特征性临床表现,主要通过内镜下活组织病理检查明确诊断。结直肠神经内分泌肿瘤治疗方法主要依靠手术治疗,早期预后良好,预后与分期和分级密切相关。

Objective

To investigate the diagnosis, therapy and prognosis of colorectal neuroendocrine neoplasm (NEN) through a retrospective analysis on the colorectal NEN clinical features.

Methods

Clinicopathological data of 25 patients with colorectal NEN from January 2006 to January 2015 in Hubei Cancer Hospital were analyzed.

Results

Three of the 25 cases of NEN occurred in appendix, 3 in ascending colon, 2 in sigmoid colon, 17 in rectum. The NEN were divided into four grades: G1 (11 cases), G2 (3 cases), NEC (8 cases), MANEC (3 cases). Immunohistochemical staining revealed that the positive rates of Syn, CgA and NSE were 96%, 68% and 92% respectively. Liver is the most common place of metastasis in NEN patients. The 5-year survival rate of stage Ⅰ and Ⅲ patients were 100% and 25% respectively, while the 5-year survival rate of stage Ⅱ patients was 50%. The survival time of 2 stage Ⅳ patients was 28 months and 37 months respectively.

Conclusions

The clinical manifestations of colorectal NEN are of non-special and endoscopic biopsy is the major diagnostic modality. The main method of treatment for colorectal NEN is surgery, and the prognosis was associated with clinical stages and grades.

表1 25例结直肠神经内分泌肿瘤患者的临床资料(例)
[1]
Ito T,Sasano HM,Osamura RY, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan[J]. J Gastroenterol, 2010, 45(2): 234-243.
[2]
Caplin M,Sundin A,Nillson O, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms[J]. Neuroendocrinology, 2012, 95(2): 88-97.
[3]
Yao J,Hassan MA,Dagohoy C, et al. One hundred years after ʺcarcinoidʺ: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States[J]. J Clini Oncol, 2008, 26(18): 3063-3072.
[4]
Modlin IM,Kidd M,Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology[J]. Gastroenterology, 2005, 128(6): 1717-1751.
[5]
Lawrence B,Gustafsson BI,Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am, 2011, 40(1): 1-18.
[6]
Panzuto F,Nasoni SM,Corleto VD, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization[J]. Endocr Relat Cancer, 2005, 12(4): 1083-1092.
[7]
Ter-Minassian M,Chan JA,Hooshmand SM, et al. Clinical Presentation, Recurrence, and Survival in Patients with Neuroendocrine Tumors: Results from a Prospective Institutional Database[J]. Endocr Relat Cancer, 2013, 20(2): 187-196.
[8]
Hainsworth JD,Spigel DR,Litchy S, et al. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study[J]. J Clini Oncol, 2006, 24(22): 3548-3554.
[9]
Landry CS,Brock G,Scoggins CR, et al. A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients[J]. Surgery, 2008, 144(3): 460-466.
[10]
Landry CS,Brock G,Scoggins CR, et al. Pproposed staging system for colon carcinoid tumors based on an analysis of 2459 patients[J]. J Am Coll Surg, 2008, 207(11): 874-881.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[3] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[7] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[8] 钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
[9] 胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[10] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[11] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[12] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
[15] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
阅读次数
全文


摘要